Drug Trial News

RSS

First clinical study of FX06 treatment against damage caused by heart attacks

Central to the study is FXO6, a peptide developed and patented by Austro-American company Fibrex Medical. Fibrex will now test the tolerability and pharmacokinetics of FX06 in humans. The peptide reduces inflammatory responses of the heart muscle that can arise after treatment for a myocardial infarction. Tests will begin immediately on the first - healthy - subjects at the Vienna General Hospital.

7 Nov 2005

Studies outline dangers of mixing stress, deprivation and tempting foods

Two studies in the October issue of Behavioral Neuroscience show that when animals are stressed, deprived and exposed to tempting food, they overeat, with different degrees of interaction.

7 Nov 2005

Resveratrol effective in lowering amyloid-beta peptides

A study published in the November 11 issue of the Journal of Biological Chemistry shows that resveratrol, a compound found in grapes and red wine, lowers the levels of the amyloid-beta peptides which cause the telltale senile plaques of Alzheimer's disease.

7 Nov 2005

Genetic profile of ovarian cancer

A newly identified gene expression profile could help predict how patients with advanced ovarian cancer will respond to chemotherapy treatment.

7 Nov 2005

HIV antiretroviral therapy does help those in third world

With preliminary results from a study in Botswana, Harvard School of Public Health researchers have found that people with HIV-1 subtype C in resource-poor settings, who receive antiretroviral (ARV) therapy, can achieve comparable results to those in the developed world.

7 Nov 2005

HIV-positive patients have shorter survival periods while awaiting liver transplants

A new study on HIV-positive patients eligible for liver transplants found that their survival while waiting for a transplant is significantly shorter than patients who are HIV-negative.

7 Nov 2005

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

7 Nov 2005

New discovery helps explain complex neurocircuitry behind body weight control

A study led by a scientific team at Beth Israel Deaconess Medical Center (BIDMC) provides another important step in our understanding of the critical role that the brain's molecular pathways play in the development of obesity and related disorders.

7 Nov 2005

Waist-to-hip ratio, not body mass index, is the best measure of heart attack risk

Waist-to-hip ratio, not body mass index (BMI), is the best obesity measure for assessing a person's risk of heart attack, concludes a global study published in this week's issue of The Lancet.

7 Nov 2005

How does a neighborhood influence physical activity and diet?

Families living in the Nellies Cave Park area near Virginia Tech are helping researchers learn about healthy lifestyles and in return are getting information about their own health.

7 Nov 2005

First study to investigate regional low birth weight rates on a national scale

Low birth weight, an important risk factor of infant mortality and childhood developmental disorders, varies more than 3-fold in regions across the U.S., according to national research conducted at Dartmouth Medical School. The study offers promise for health care experts in an area of prenatal health where progress has been elusive.

7 Nov 2005

Daily dose of probiotics keeps workers healthy

Workers who take probiotics daily are less likely to be off work with common illnesses, such as colds and gastroenteritis, than workers who don't.

7 Nov 2005

Young hockey player injuries studied - suprising findings

Unintentional collisions and falling into the boards cause more injuries in young hockey players than the practice of body checking, researchers at the University at Buffalo have found.

3 Nov 2005

Exercise is good for multiple sclerosis, but it must be done correctly

Aerobic exercise is thought to help persons with multiple sclerosis fight fatigue, the most common symptom of the disease. Yet MS also appears to cause the body to heat up more quickly, compromising the ability to exercise.

3 Nov 2005

Largest study to date on risk factors associated with primary biliary cirrhosis

A case-control study of more than 2000 people has identified a number of factors that may induce primary biliary cirrhosis (PBC) in genetically susceptible individuals. These include a history of urinary tract infections, hormone replacement therapy, tobacco use, and nail polish use.

3 Nov 2005

Clinicans warned about randomized clinical trials

A review article in the November 2 issue of JAMA: The Journal of the American Medical Association, suggests clinicians ought to view with skepticism the results of randomized clinical trials stopped early because of apparent benefit.

3 Nov 2005

Ospemifine may also help to prevent breast cancer

A tamoxifen-like drug developed by UC Davis and Finnish researchers, now in clinical testing as a treatment for vaginal atrophy, may also help to prevent breast cancer, two preliminary studies suggest.

3 Nov 2005

Issues faced by cancer patients - assessement - impact - implications

New study findings showcased at the 13th European Cancer Conference (ECCO) have shed further light on the manifold factors which must be considered when managing patients with cancer. Studies from around Europe looked at a number of the issues faced by cancer patients and assessed their impact and associated implications.

3 Nov 2005

Testicular cancer survivors can still have children

The overall rate of fatherhood after treatment for testicular cancer is high, but the ability to conceive and the time to conception are influenced by the type and intensity of treatment, according to a new study in the November 2 issue of the Journal of the National Cancer Institute.

3 Nov 2005

Accumulation of fat in the liver linked to hypertension

The accumulation of fat in the liver, or "fatty liver," resulting from accumulation of central body fat, and perhaps not alcohol consumption, may represent an important underlying mechanism for the association between liver enzymes and hypertension.

3 Nov 2005